secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2026-01-22T23:59:59+00:00
Accession:  0001493152-26-003237
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics extends ATM equity distribution agreement with Dawson James
---------------------------------------------------------------------

- On January 22, 2026, Oragenics amended its at-the-market sales agreement with Dawson James Securities.
- The amendment extends the agreement term until all shares are sold or the shelf registration expires.
- No other terms of the original October 11, 2024 agreement were modified.
- The ATM facility allows the company to sell common stock from time to time on NYSE American.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315226003237/0001493152-26-003237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315226003237/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-003237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer